Qualitative hCG testing provides a rapid assessment of pregnancy status. A positive result most often indicates pregnancy but may also reflect non-placental hCG production (pituitary hCG in menopausal women, hCG-producing tumors). A negative result generally excludes pregnancy but can also be observed in samples with extremely high or low hCG concentrations. Test results must always be interpreted in the context of the patient’s history, physical exam, timing of specimen collection, and results of other laboratory tests. [back to top]
This test should be performed in clinical settings that require a rapid assessment of pregnancy status when quantitative serum/plasma testing is not available within a clinically acceptable time frame. [back to top]
Do not order qualitative hCG testing when monitoring abnormal pregnancy or making assessments about pregnancy viability. Qualitative urine hCG testing is also inappropriate for the evaluation and monitoring of hCG-secreting tumors. For both of these indications, serial quantitative plasma or serum hCG measurement is recommended. [back to top]
A positive result indicates presence of hCG, whereas a negative result indicates absence of hCG. It does not identify the source of hCG production or provide a numeric value that can be trended across multiple timepoints. [back to top]
No. Qualitative hCG testing is a rapid screening tool. Although test results are most often correct and can be used to guide clinical decisions, false negative and false positive results can occur. Serum/plasma quantitative hCG testing is considered the gold standard as it eliminates many of the limitations of qualitative testing. Ultrasound can also be performed to confirm viable intrauterine pregnancy. [back to top]
False negative results can be encountered:
1. Early in pregnancy when hCG concentrations are low, particularly in dilute urine.
2. Later in pregnancy when hCG and/or hCG variant concentrations are high, known as the “hook effect”.
Heterophile antibodies may cause false negative or false positive results in serum testing but this is generally not a concern when testing urine.
Invalid results (control line fails to appear) may also be observed when using certain test kits if the patient is taking high-dose biotin. Qualitative testing also introduces human error as it requires subjective visual interpretation and manual documentation of test results in the medical record. [back to top]
N/A [back to top]
1.If there is a high clinical suspicion for pregnancy and qualitative urine hCG testing is negative OR if a numeric hCG value is needed to guide management of abnormal pregnancy, quantitative serum/plasma hCG testing should be performed.
2.If a numeric value is not needed, qualitative serum hCG testing may be performed. This eliminates the possibility of false negative results caused by hCG variants found only in urine. However, because specimen processing is required to obtain serum, this testing is typically performed in a central laboratory, which increases the time from collection to result. [back to top]
Last reviewed: July 2025. The content for Optimal Testing: the Association for Diagnostics & Laboratory Medicine’s (ADLM) Guide to Lab Test Utilization has been developed and approved by the the Academy of Diagnostics & Laboratory Medicine and ADLM’s Science and Practice Core Committee.
As the fields of laboratory medicine and diagnostic testing continue to grow at an incredible rate, the knowledge and expertise of clinical laboratory professionals is essential to ensure that patients received the highest quality and most useful laboratory tests. ADLM’s Academy and Science and Practice Core Committee have developed a test utilization resource focusing on commonly misused tests in hospitals and clinics. Improper test utilization can result in poor patient outcomes and waste in the healthcare system. This important resource geared toward medical professionals recommends better tests and diagnostic practices. Always consult your laboratory director to make sure these recommendations are appropriate for your patient population.